Profile data is unavailable for this security.
About the company
SomnoMed Limited is engaged in producing and selling devices for the oral treatment of sleep-related disorders. It provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. It is focused on the commercialization of the SomnoDent Mandibular Advancement Splint and other oral devices for sleep-related disorders in Australia and overseas. Its segments include North America, Europe, Asia Pacific, CORE, and RSS. Its SomnoDent product line includes SomnoDent Avant, SomnoDent Classic, SomnoDent Flex, SomnoDent Fusion, Herbst Advance Elite and Herbst Advance. Its SomMorning Repositioner is designed to help return their mandible back to its pre-treatment centric position. Its SomnoBrux Michigan splint is a custom fit, acrylic splint (dental guard) for upper teeth designed to protect the teeth from grinding and scraping during Bruxism. It also offers SomTabs, which are cleaning tablets that are developed to clean oral appliances.
- Revenue in AUD (TTM)111.52m
- Net income in AUD-3.46m
- Incorporated1987
- Employees300.00
- LocationSomnomed LtdLevel 3, 20 Clarke St, Crows NestSYDNEY 2065AustraliaAUS
- Phone+61 29467-0400
- Fax+61 29467-0467
- Websitehttps://somnomed.com/en/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mach7 Technologies Ltd | 34.64m | -6.20m | 83.43m | 90.00 | -- | 1.83 | 80.09 | 2.41 | -0.0259 | -0.0259 | 0.1443 | 0.194 | 0.5048 | -- | 6.07 | -- | -9.04 | -7.68 | -11.51 | -9.10 | 94.24 | 95.77 | -17.90 | -20.36 | -- | -26.29 | 0.024 | -- | 15.42 | 12.93 | 22.19 | -- | 84.49 | -- |
| Vitrafy Life Sciences Ltd | 66.28k | -14.15m | 85.53m | -- | -- | 5.05 | -- | 1,290.47 | -0.1807 | -0.1807 | 0.0008 | 0.3391 | 0.0022 | -- | 0.2465 | -- | -47.44 | -- | -49.60 | -- | -- | -- | -21,351.00 | -- | -- | -- | 0.0158 | -- | 75.17 | -- | -213.76 | -- | -- | -- |
| Optiscan Imaging Ltd | 951.95k | -6.31m | 88.76m | 8.00 | -- | 9.27 | -- | 93.23 | -0.0075 | -0.0075 | 0.0011 | 0.0092 | 0.0727 | 0.257 | 0.5149 | -- | -48.21 | -49.13 | -55.07 | -57.06 | 50.41 | 11.82 | -663.05 | -405.67 | 4.76 | -- | 0.1611 | -- | -17.62 | -4.38 | -4.15 | -- | 35.75 | -- |
| Cyclopharm Limited | 29.68m | -13.38m | 97.69m | 95.00 | -- | 2.49 | -- | 3.29 | -0.1214 | -0.1214 | 0.2694 | 0.3248 | 0.4946 | 0.9306 | 6.28 | 312,380.80 | -22.29 | -15.69 | -27.32 | -18.73 | 61.48 | 67.79 | -45.07 | -31.55 | 1.94 | -- | 0.181 | -- | -0.694 | 14.35 | -180.75 | -- | 15.28 | -- |
| SDI Ltd | 110.38m | 12.16m | 105.20m | 300.00 | 8.65 | 1.02 | 6.18 | 0.953 | 0.1023 | 0.1023 | 0.9287 | 0.8638 | 0.7833 | 1.45 | 5.43 | -- | 8.63 | 7.81 | 10.31 | 9.29 | 62.85 | 59.86 | 11.02 | 9.06 | 1.62 | 28.73 | 0.1448 | 42.64 | -0.7392 | 10.38 | 16.69 | 23.47 | 13.53 | 12.94 |
| Austco Healthcare Ltd | 81.41m | 5.93m | 123.67m | 174.00 | 20.61 | 2.32 | 14.05 | 1.52 | 0.016 | 0.016 | 0.2197 | 0.1421 | 1.02 | 3.91 | 4.67 | -- | 7.43 | 9.35 | 10.83 | 13.33 | 52.05 | 53.07 | 7.29 | 8.39 | 1.28 | -- | 0.1233 | -- | 39.98 | 19.76 | -16.15 | 18.83 | 25.65 | -- |
| Somnomed Ltd | 111.52m | -3.46m | 152.91m | 300.00 | -- | 3.26 | 66.77 | 1.37 | -0.0163 | -0.0163 | 0.5262 | 0.2147 | 1.48 | 6.53 | 7.25 | -- | -4.58 | -9.15 | -6.76 | -13.46 | 59.86 | 60.62 | -3.10 | -6.89 | 1.25 | -0.6067 | 0.1475 | -- | 21.63 | 14.24 | 71.77 | -- | 12.72 | -- |
| Epiminder Ltd | -100.00bn | -100.00bn | 162.92m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -93.22 | -- | -99.64 | -- | -- | -- |
| EMvision Medical Devices Ltd | 5.63m | -9.81m | 165.43m | -- | -- | 16.40 | -- | 29.39 | -0.1148 | -0.1148 | 0.0659 | 0.1086 | 0.2847 | -- | 694.01 | -- | -49.59 | -47.15 | -58.91 | -58.42 | -- | -- | -174.21 | -105.97 | -- | -93.34 | 0.2758 | -- | -51.31 | 41.83 | -259.23 | -- | -- | -- |
| Lumos Diagnostics Holdings Ltd | 17.53m | -10.16m | 214.17m | -- | -- | 23.22 | -- | 12.22 | -0.0148 | -0.0148 | 0.0258 | 0.0116 | 0.5205 | 7.04 | 4.91 | -- | -30.15 | -40.19 | -54.60 | -61.16 | 62.95 | 52.57 | -57.93 | -132.46 | 0.6816 | -10.69 | 0.5315 | -- | 11.40 | 17.12 | 16.40 | -- | -61.58 | -- |
| Holder | Shares | % Held |
|---|---|---|
| TDMAM Pty Ltd.as of 04 Dec 2025 | 54.50m | 24.95% |
| Australian Ethical Investments Ltd. (Investment Management)as of 12 Dec 2024 | 31.40m | 14.37% |
| FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 2025 | 12.15m | 5.56% |
| Mutual Trust Pty Ltd.as of 16 Sep 2024 | 7.75m | 3.55% |
| FIL Pensions Managementas of 30 Jun 2025 | 3.07m | 1.40% |
| DFA Australia Ltd.as of 31 Dec 2025 | 131.43k | 0.06% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 1.27k | 0.00% |
